Duchenne muscular dystrophy (DMD) is an X-linked inherited dystrophinopathy, with an incidence of 1 in 3,600 - 5,000 male live-born infants. The leading cause of death is often cardiomyopathy-related heart failure. Given the progressive nature of the disorder with involvement of skeletal muscle, respiratory and cardiac function, perioperative care remains challenging with an increased incidence of perioperative morbidity and mortality. Perioperative care can be challenging due to life-threatening perioperative adverse events related to associated end-organ effects, as well as sensitivity to various anesthetic agents, rhabdomyolysis, hyperkalemia, hyperthermia, and cardiac arrest. We present a 22-year-old DMD patient with left ventricular assisted device (LVAD), who presented for repair of both left distal femur and tibial diaphysis fractures. Anesthetic care included the unique combination of total intravenous anesthesia with dexmedetomidine and remimazolam combined with regional anesthesia including a supra-inguinal fascia iliaca block, saphenous nerve block, and popliteal nerve block. The basics of dystrophinopathies are presented, perioperative concerns discussed, and previous reports of the use of regional anesthesia as an adjunct to general anesthesia in adult and pediatric patients with DMD are reviewed.
Keyphrases
- duchenne muscular dystrophy
- cardiac surgery
- heart failure
- left ventricular
- patients undergoing
- skeletal muscle
- muscular dystrophy
- healthcare
- acute kidney injury
- cardiac arrest
- palliative care
- minimally invasive
- quality improvement
- case report
- coronary artery bypass
- risk factors
- cardiac resynchronization therapy
- pain management
- affordable care act
- acute myocardial infarction
- cardiopulmonary resuscitation
- prostate cancer
- multiple sclerosis
- mitral valve
- total knee arthroplasty
- emergency department
- early onset
- high dose
- coronary artery disease
- young adults
- metabolic syndrome
- adipose tissue
- acute coronary syndrome
- left atrial
- health insurance
- transcatheter aortic valve replacement
- childhood cancer
- left ventricular assist device
- gestational age
- surgical site infection